Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

1.

Current state and limitations of daily oral therapy for treatment.

Solomon DA, Sax PE.

Curr Opin HIV AIDS. 2015 Jul;10(4):219-25. doi: 10.1097/COH.0000000000000165.

PMID:
26049945
2.

Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.

Longenecker CT, Kitch D, Sax PE, Daar ES, Tierney C, Gupta SK, McComsey GA; AIDS Clinical Trials Group Study A5224s Team.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):168-77. doi: 10.1097/QAI.0000000000000557.

PMID:
26009829
3.

Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study.

Sise ME, Backman ES, Wenger JB, Wood BR, Sax PE, Chung RT, Thadhani R, Kim AY.

PLoS One. 2015 Apr 29;10(4):e0124139. doi: 10.1371/journal.pone.0124139. eCollection 2015.

4.

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, Pozniak A, Thompson M, Podzamczer D, Molina JM, Oka S, Koenig E, Trottier B, Andrade-Villanueva J, Crofoot G, Custodio JM, Plummer A, Zhong L, Cao H, Martin H, Callebaut C, Cheng AK, Fordyce MW, McCallister S; GS-US-292-0104/0111 Study Team.

Lancet. 2015 Jun 27;385(9987):2606-15. doi: 10.1016/S0140-6736(15)60616-X. Epub 2015 Apr 15.

PMID:
25890673
5.

Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.

Gupta SK, Kitch D, Tierney C, Daar ES, Sax PE, Melbourne K, Ha B, McComsey GA; AIDS Clinical Trials Group Study A5224s Team.

Open Forum Infect Dis. 2014 Apr 16;1(1):ofu003. doi: 10.1093/ofid/ofu003. eCollection 2014 Mar.

6.

A Welcome to Open Forum Infectious Diseases (OFID).

Sax PE.

Open Forum Infect Dis. 2014 Feb 18;1(1):ofu001. doi: 10.1093/ofid/ofu001. eCollection 2014 Mar. No abstract available.

7.

The clinical role and cost-effectiveness of long-acting antiretroviral therapy.

Ross EL, Weinstein MC, Schackman BR, Sax PE, Paltiel AD, Walensky RP, Freedberg KA, Losina E.

Clin Infect Dis. 2015 Apr 1;60(7):1102-10. doi: 10.1093/cid/ciu1159. Epub 2015 Jan 12.

PMID:
25583979
8.

Cost-effectiveness of genotype testing for primary resistance in Brazil.

Luz PM, Morris BL, Grinsztejn B, Freedberg KA, Veloso VG, Walensky RP, Losina E, Nakamura YM, Girouard MP, Sax PE, Struchiner CJ, Paltiel AD.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):152-61. doi: 10.1097/QAI.0000000000000426.

9.

HIV cure strategies: how good must they be to improve on current antiretroviral therapy?

Sax PE, Sypek A, Berkowitz BK, Morris BL, Losina E, Paltiel AD, Kelly KA, Seage GR 3rd, Walensky RP, Weinstein MC, Eron J, Freedberg KA.

PLoS One. 2014 Nov 14;9(11):e113031. doi: 10.1371/journal.pone.0113031. eCollection 2014. Erratum in: PLoS One. 2015;10(1):e0117762.

10.

Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.

Venuto CS, Mollan K, Ma Q, Daar ES, Sax PE, Fischl M, Collier AC, Smith KY, Tierney C, Morse GD.

J Antimicrob Chemother. 2014 Dec;69(12):3300-10. doi: 10.1093/jac/dku303. Epub 2014 Aug 25.

PMID:
25159623
11.

Beginning antiretroviral therapy for patients with HIV.

Johnson JA, Sax PE.

Infect Dis Clin North Am. 2014 Sep;28(3):421-38. doi: 10.1016/j.idc.2014.06.003. Review.

PMID:
25151564
12.

Beta-glucan for Pneumocystis pneumonia diagnosis in persons with AIDS: authors' reply.

Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE.

AIDS. 2013 Nov 28;27(18):2967-8. doi: 10.1097/QAD.0000000000000018. No abstract available.

PMID:
25119691
13.

Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.

Wyatt CM, Kitch D, Gupta SK, Tierney C, Daar ES, Sax PE, Ha B, Melbourne K, McComsey GA; AIDS Clinical Trials Group Study A5224s Team.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):36-44. doi: 10.1097/QAI.0000000000000245.

PMID:
25117929
14.

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.

Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbell TB, Sax PE, Gulick RM, Na L, O'Keefe L, Robertson KR, Tierney C.

Ann Intern Med. 2014 Jul 1;161(1):1-10. doi: 10.7326/M14-0293. Erratum in: Ann Intern Med. 2014 Aug 19;161(4):308.

15.

Evaluation of Fever and infections in cardiac surgery patients.

Rhee C, Sax PE.

Semin Cardiothorac Vasc Anesth. 2015 Jun;19(2):143-53. doi: 10.1177/1089253214538524. Epub 2014 Jun 22.

PMID:
24958717
16.

Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion.

Al-Hajjar SH, Frayha HH, Al-Hazmi M, Batawi R, McIntosh K, Sax PE, Al-Thawadi S, Al-Jumaah S, Busch MP, Hanhauser E, Kuritzkes DR, Li JZ, Henrich TJ.

AIDS. 2014 Jun 19;28(10):1539-41. doi: 10.1097/QAD.0000000000000268. No abstract available.

17.

Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study.

Sax PE, Zolopa A, Brar I, Elion R, Ortiz R, Post F, Wang H, Callebaut C, Martin H, Fordyce MW, McCallister S.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):52-8. doi: 10.1097/QAI.0000000000000225.

PMID:
24872136
18.

Getting started with your HIV care.

Johnson JA, Sax PE.

Posit Aware. 2013 Sep-Oct;25(6):10-4. No abstract available.

PMID:
24847580
19.

Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.

Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS.

Clin Infect Dis. 2014 Sep 15;59(6):888-96. doi: 10.1093/cid/ciu367. Epub 2014 May 19.

PMID:
24842909
20.

Initial therapy for HIV: can less be more?

Sax PE.

Lancet Infect Dis. 2014 Jul;14(7):535-7. doi: 10.1016/S1473-3099(14)70753-4. Epub 2014 Apr 27. No abstract available.

PMID:
24783987
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk